{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:05:55Z","timestamp":1794841555265,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ITF TCFS grant GHP\/074\/20SZ; CUHK internal grants"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Extracellular vesicles (EVs) are promising drug-delivery vehicles owing to their biocompatibility and low immunogenicity. Genetic engineering of a membrane-bound EV-sorting scaffold protein empowers EVs by installing targeting moieties on the surface and enriching therapeutic cargo in the lumen. However, the choice of scaffold proteins with simple structures and short sequences is limited. Here, we conduct mass spectrometry-based proteomic studies and identify ENPP1 as a superior scaffold protein. Furthermore, we show that a truncated 144-amino acid variant, EN144, efficiently loads diverse therapeutic cargoes and outperforms conventional scaffolds. By fusing EN144 to the IL-6 decoy receptor gp130, we create engineered decoy EVs that potently inhibit inflammatory IL-6 trans-signaling. In mouse models, these EVs reduce inflammation, improve survival in sepsis, and, when targeted to cartilage, alleviate tissue damage in osteoarthritis. Our work establishes EN144 as a minimal, high-performance scaffold for EV engineering and demonstrates its broad therapeutic potential for inflammatory diseases.<\/jats:p>","DOI":"10.1038\/s41467-026-70451-x","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:35:34Z","timestamp":1773120934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extracellular vesicle engineering using a small scaffold protein"],"prefix":"10.1038","volume":"17","author":[{"given":"Wenjing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6083-6753","authenticated-orcid":false,"given":"Shizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-1271","authenticated-orcid":false,"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChangYan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-7710","authenticated-orcid":false,"given":"Zhongze","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7825-5087","authenticated-orcid":false,"given":"Evan Yi-Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8112-7625","authenticated-orcid":false,"given":"Jiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9744-1707","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"70451_CR1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann, I. K., Wood, M. J. A. & Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 16, 748\u2013759 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"70451_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02081-0","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu, Q., Li, D., Pan, X. & Liang, Y. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J. Nanobiotechnology 21, 334 (2023).","journal-title":"J. Nanobiotechnology"},{"key":"70451_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01472-z","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J. Nanobiotechnology 20, 279 (2022).","journal-title":"J. Nanobiotechnology"},{"key":"70451_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","volume":"31","author":"J Radler","year":"2023","unstructured":"Radler, J., Gupta, D., Zickler, A. & Andaloussi, S. E. Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Mol. Ther. 31, 1231\u20131250 (2023).","journal-title":"Mol. Ther."},{"key":"70451_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40453-0","volume":"14","author":"W Zheng","year":"2023","unstructured":"Zheng, W. et al. Identification of scaffold proteins for improved endogenous engineering of extracellular vesicles. Nat. Commun. 14, 4734 (2023).","journal-title":"Nat. Commun."},{"key":"70451_CR6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ymthe.2021.01.020","volume":"29","author":"K Dooley","year":"2021","unstructured":"Dooley, K. et al. A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Mol. Ther. 29, 1729\u20131743 (2021).","journal-title":"Mol. Ther."},{"key":"70451_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213\u2013228 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70451_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrc3640","volume":"14","author":"ME Hemler","year":"2014","unstructured":"Hemler, M. E. Tetraspanin proteins promote multiple cancer stages. Nat. Rev. Cancer 14, 49\u201360 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"70451_CR9","doi-asserted-by":"publisher","first-page":"e12130","DOI":"10.1002\/jev2.12130","volume":"10","author":"AM Silva","year":"2021","unstructured":"Silva, A. M. et al. Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution. J. Extracell. Vesicles 10, e12130 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"70451_CR10","doi-asserted-by":"publisher","unstructured":"Gupta, D. et al. Modulation of pro-inflammatory IL-6 trans-signaling axis by splice switching oligonucleotides as a therapeutic modality in inflammation. Cells 12, https:\/\/doi.org\/10.3390\/cells12182285 (2023).","DOI":"10.3390\/cells12182285"},{"key":"70451_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41392-021-00816-9","volume":"6","author":"YY Zhang","year":"2021","unstructured":"Zhang, Y. Y. & Ning, B. T. Signaling pathways and intervention therapies in sepsis. Signal Transduct. Target. Ther. 6, 407 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70451_CR12","first-page":"56","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu, D. et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil. Med. Res. 9, 56 (2022).","journal-title":"Mil. Med. Res."},{"key":"70451_CR13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.7150\/thno.78639","volume":"13","author":"J Li","year":"2023","unstructured":"Li, J. et al. Targeted and responsive biomaterials in osteoarthritis. Theranostics 13, 931\u2013954 (2023).","journal-title":"Theranostics"},{"key":"70451_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J. P. & Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33\u201342 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70451_CR15","doi-asserted-by":"publisher","first-page":"e2004433","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Cytokines: from clinical significance to quantification. Adv. Sci. 8, e2004433 (2021).","journal-title":"Adv. Sci."},{"key":"70451_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Bozec, A., Ramming, A. & Schett, G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat. Rev. Rheumatol. 15, 9\u201317 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70451_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jama.2020.22171","volume":"325","author":"JN Katz","year":"2021","unstructured":"Katz, J. N., Arant, K. R. & Loeser, R. F. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA 325, 568\u2013578 (2021).","journal-title":"JAMA"},{"key":"70451_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","volume":"9","author":"OJ McElvaney","year":"2021","unstructured":"McElvaney, O. J., Curley, G. F., Rose-John, S. & McElvaney, N. G. Interleukin-6: obstacles to targeting a complex cytokine in critical illness. Lancet Respir. Med. 9, 643\u2013654 (2021).","journal-title":"Lancet Respir. Med."},{"key":"70451_CR19","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller, J., Chalaris, A., Schmidt-Arras, D. & Rose-John, S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813, 878\u2013888 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"70451_CR20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John, S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 8, 1237\u20131247 (2012).","journal-title":"Int. J. Biol. Sci."},{"key":"70451_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrd.2018.45","volume":"17","author":"C Garbers","year":"2018","unstructured":"Garbers, C., Heink, S., Korn, T. & Rose-John, S. Interleukin-6: designing specific therapeutics for a complex cytokine. Nat. Rev. Drug Discov. 17, 395\u2013412 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70451_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","volume":"268","author":"T Jostock","year":"2001","unstructured":"Jostock, T. et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268, 160\u2013167 (2001).","journal-title":"Eur. J. Biochem."},{"key":"70451_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/glia.24098","volume":"70","author":"M Sadri","year":"2022","unstructured":"Sadri, M. et al. Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFalpha decoy. Glia 70, 256\u2013272 (2022).","journal-title":"Glia"},{"key":"70451_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41586-020-2066-6","volume":"579","author":"MD Keller","year":"2020","unstructured":"Keller, M. D. et al. Decoy exosomes provide protection against bacterial toxins. Nature 579, 260\u2013264 (2020).","journal-title":"Nature"},{"key":"70451_CR25","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41551-021-00792-z","volume":"5","author":"D Gupta","year":"2021","unstructured":"Gupta, D. et al. Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles. Nat. Biomed. Eng. 5, 1084\u20131098 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"70451_CR26","doi-asserted-by":"publisher","first-page":"120435","DOI":"10.1016\/j.biomaterials.2020.120435","volume":"266","author":"M Conceicao","year":"2021","unstructured":"Conceicao, M. et al. Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle. Biomaterials 266, 120435 (2021).","journal-title":"Biomaterials"},{"key":"70451_CR27","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1039\/C8NR08720B","volume":"11","author":"AF Saleh","year":"2019","unstructured":"Saleh, A. F. et al. Extracellular vesicles induce minimal hepatotoxicity and immunogenicity. Nanoscale 11, 6990\u20137001 (2019).","journal-title":"Nanoscale"},{"key":"70451_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2024.04.009","volume":"369","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Surface functionalization of exosomes for chondrocyte-targeted siRNA delivery and cartilage regeneration. J. Control. Release 369, 493\u2013505 (2024).","journal-title":"J. Control. Release"},{"key":"70451_CR29","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1021\/acs.jproteome.8b00459","volume":"17","author":"X Wu","year":"2018","unstructured":"Wu, X., Li, L., Iliuk, A. & Tao, W. A. Highly efficient phosphoproteome capture and analysis from urinary extracellular vesicles. J. Proteome Res. 17, 3308\u20133316 (2018).","journal-title":"J. Proteome Res."},{"key":"70451_CR30","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.ymthe.2018.09.015","volume":"26","author":"RA Haraszti","year":"2018","unstructured":"Haraszti, R. A. et al. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol. Ther. 26, 2838\u20132847 (2018).","journal-title":"Mol. Ther."},{"key":"70451_CR31","doi-asserted-by":"publisher","first-page":"1663043","DOI":"10.1080\/20013078.2019.1663043","volume":"8","author":"G Corso","year":"2019","unstructured":"Corso, G. et al. Systematic characterization of extracellular vesicle sorting domains and quantification at the single molecule\u2014single vesicle level by fluorescence correlation spectroscopy and single particle imaging. J. Extracell. Vesicles 8, 1663043 (2019).","journal-title":"J. Extracell. Vesicles"},{"key":"70451_CR32","doi-asserted-by":"publisher","unstructured":"Yan, W. et al. Chondrocyte-targeted delivery system of sortase A-engineered extracellular vesicles silencing MMP13 for osteoarthritis therapy. Adv. Healthc. Mater. e2303510. https:\/\/doi.org\/10.1002\/adhm.202303510 (2024).","DOI":"10.1002\/adhm.202303510"},{"key":"70451_CR33","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1039\/D0BM00427H","volume":"8","author":"Y Ye","year":"2020","unstructured":"Ye, Y. et al. An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells. Biomater. Sci. 8, 2966\u20132976 (2020).","journal-title":"Biomater. Sci."},{"key":"70451_CR34","doi-asserted-by":"publisher","first-page":"e12225","DOI":"10.1002\/jev2.12225","volume":"11","author":"X Osteikoetxea","year":"2022","unstructured":"Osteikoetxea, X. et al. Engineered Cas9 extracellular vesicles as a novel gene editing tool. J. Extracell. Vesicles 11, e12225 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"70451_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12301-7","volume":"10","author":"H Gotzke","year":"2019","unstructured":"Gotzke, H. et al. The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications. Nat. Commun. 10, 4403 (2019).","journal-title":"Nat. Commun."},{"key":"70451_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.molcel.2011.03.010","volume":"42","author":"J Karanicolas","year":"2011","unstructured":"Karanicolas, J. et al. A de novo protein binding pair by computational design and directed evolution. Mol. Cell 42, 250\u2013260 (2011).","journal-title":"Mol. Cell"},{"key":"70451_CR37","doi-asserted-by":"publisher","first-page":"1440131","DOI":"10.1080\/20013078.2018.1440131","volume":"7","author":"Y Yang","year":"2018","unstructured":"Yang, Y., Hong, Y., Cho, E., Kim, G. B. & Kim, I. S. Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery. J. Extracell. Vesicles 7, 1440131 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"70451_CR38","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1093\/nar\/30.2.e9","volume":"30","author":"Y Durocher","year":"2002","unstructured":"Durocher, Y., Perret, S. & Kamen, A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30, E9 (2002).","journal-title":"Nucleic Acids Res."},{"key":"70451_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/1535-7163.MCT-20-0484","volume":"20","author":"ND Lewis","year":"2021","unstructured":"Lewis, N. D. et al. Exosome surface display of IL12 results in tumor-retained pharmacology with superior potency and limited systemic exposure compared with recombinant IL12. Mol. Cancer Ther. 20, 523\u2013534 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"70451_CR40","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1021\/acsnano.3c05847","volume":"18","author":"W Pei","year":"2024","unstructured":"Pei, W. et al. Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles. ACS Nano 18, 2782\u20132799 (2024).","journal-title":"ACS Nano"},{"key":"70451_CR41","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cub.2022.03.005","volume":"32","author":"IA Nikonorova","year":"2022","unstructured":"Nikonorova, I. A. et al. Isolation, profiling, and tracking of extracellular vesicle cargo in Caenorhabditis elegans. Curr. Biol. 32, 1924\u20131936 e1926 (2022).","journal-title":"Curr. Biol."},{"key":"70451_CR42","doi-asserted-by":"publisher","first-page":"4834791","DOI":"10.1155\/2022\/4834791","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li, Z., He, Q., Peng, J., Yan, Y. & Fu, C. Identification of downregulated exosome-associated gene ENPP1 as a novel lipid metabolism and immune-associated biomarker for hepatocellular carcinoma. J. Oncol. 2022, 4834791 (2022).","journal-title":"J. Oncol."},{"key":"70451_CR43","doi-asserted-by":"publisher","first-page":"e2308131","DOI":"10.1002\/advs.202308131","volume":"11","author":"Y An","year":"2024","unstructured":"An, Y. et al. Tumor exosomal ENPP1 hydrolyzes cGAMP to inhibit cGAS-STING signaling. Adv. Sci. 11, e2308131 (2024).","journal-title":"Adv. Sci."},{"key":"70451_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-pathmechdis-051222-121126","volume":"19","author":"CR Ferreira","year":"2024","unstructured":"Ferreira, C. R., Carpenter, T. O. & Braddock, D. T. ENPP1 in blood and bone: skeletal and soft tissue diseases induced by ENPP1 deficiency. Annu. Rev. Pathol. 19, 507\u2013540 (2024).","journal-title":"Annu. Rev. Pathol."},{"key":"70451_CR45","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.str.2012.09.001","volume":"20","author":"S Jansen","year":"2012","unstructured":"Jansen, S. et al. Structure of NPP1, an ectonucleotide pyrophosphatase\/phosphodiesterase involved in tissue calcification. Structure 20, 1948\u20131959 (2012).","journal-title":"Structure"},{"key":"70451_CR46","doi-asserted-by":"publisher","first-page":"101526","DOI":"10.1016\/j.jbc.2021.101526","volume":"298","author":"R Borza","year":"2022","unstructured":"Borza, R., Salgado-Polo, F., Moolenaar, W. H. & Perrakis, A. Structure and function of the ecto-nucleotide pyrophosphatase\/phosphodiesterase (ENPP) family: tidying up diversity. J. Biol. Chem. 298, 101526 (2022).","journal-title":"J. Biol. Chem."},{"key":"70451_CR47","doi-asserted-by":"publisher","unstructured":"Corbeil, D. et al. Uptake and fate of extracellular membrane vesicles: nucleoplasmic reticulum-associated late endosomes as a new gate to intercellular communication. Cells 9, https:\/\/doi.org\/10.3390\/cells9091931 (2020).","DOI":"10.3390\/cells9091931"},{"key":"70451_CR48","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1096\/fj.201901830R","volume":"34","author":"M Sun","year":"2020","unstructured":"Sun, M., Luong, G., Plastikwala, F. & Sun, Y. Control of Rab7a activity and localization through endosomal type Igamma PIP 5-kinase is required for endosome maturation and lysosome function. FASEB J. 34, 2730\u20132748 (2020).","journal-title":"FASEB J."},{"key":"70451_CR49","doi-asserted-by":"publisher","first-page":"113801","DOI":"10.1016\/j.addr.2021.05.011","volume":"175","author":"P Escude Martinez de Castilla","year":"2021","unstructured":"Escude Martinez de Castilla, P. et al. Extracellular vesicles as a drug delivery system: a systematic review of preclinical studies. Adv. Drug Deliv. Rev. 175, 113801 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"70451_CR50","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3892\/ijmm.2014.1663","volume":"33","author":"C Grange","year":"2014","unstructured":"Grange, C. et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int. J. Mol. Med. 33, 1055\u20131063 (2014).","journal-title":"Int. J. Mol. Med."},{"key":"70451_CR51","doi-asserted-by":"publisher","unstructured":"Driedonks, T. et al. Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina. J. Extracell. Biol. 1, https:\/\/doi.org\/10.1002\/jex2.59 (2022).","DOI":"10.1002\/jex2.59"},{"key":"70451_CR52","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar, S. et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546, 498\u2013503 (2017).","journal-title":"Nature"},{"key":"70451_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0223-5","volume":"51","author":"Murphy DE","year":"2019","unstructured":"Murphy D.E. et al. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp. Mol. Med. 51, 1\u201312 (2019).","journal-title":"Exp. Mol. Med."},{"key":"70451_CR54","doi-asserted-by":"publisher","first-page":"e12085","DOI":"10.1002\/jev2.12085","volume":"10","author":"M Kang","year":"2021","unstructured":"Kang, M., Jordan, V., Blenkiron, C. & Chamley, L. W. Biodistribution of extracellular vesicles following administration into animals: a systematic review. J. Extracell. Vesicles 10, e12085 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"70451_CR55","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332\u2013343 (2018).","journal-title":"Nat. Cell Biol."},{"key":"70451_CR56","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41565-023-01585-y","volume":"19","author":"R Liam-Or","year":"2024","unstructured":"Liam-Or, R. et al. Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent. Nat. Nanotechnol. 19, 846\u2013855 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"70451_CR57","doi-asserted-by":"publisher","first-page":"1324730","DOI":"10.1080\/20013078.2017.1324730","volume":"6","author":"X Zhu","year":"2017","unstructured":"Zhu, X. et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J. Extracell. Vesicles 6, 1324730 (2017).","journal-title":"J. Extracell. Vesicles"},{"key":"70451_CR58","doi-asserted-by":"publisher","first-page":"31027","DOI":"10.3402\/jev.v5.31027","volume":"5","author":"ME Hung","year":"2016","unstructured":"Hung, M. E. & Leonard, J. N. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J. Extracell. Vesicles 5, 31027 (2016).","journal-title":"J. Extracell. Vesicles"},{"key":"70451_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima, R. et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat. Commun. 9, 1305 (2018).","journal-title":"Nat. Commun."},{"key":"70451_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.CCM.0000150025.79100.7D","volume":"33","author":"E Watanabe","year":"2005","unstructured":"Watanabe, E. et al. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit. Care Med. 33, 89\u201397 (2005).","journal-title":"Crit. Care Med."},{"key":"70451_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cytogfr.2012.04.001","volume":"23","author":"C Garbers","year":"2012","unstructured":"Garbers, C. et al. Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev. 23, 85\u201397 (2012).","journal-title":"Cytokine Growth Factor Rev."},{"key":"70451_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cytogfr.2020.04.003","volume":"55","author":"J Lokau","year":"2020","unstructured":"Lokau, J. & Garbers, C. Biological functions and therapeutic opportunities of soluble cytokine receptors. Cytokine Growth Factor Rev. 55, 94\u2013108 (2020).","journal-title":"Cytokine Growth Factor Rev."},{"key":"70451_CR63","doi-asserted-by":"publisher","first-page":"101228","DOI":"10.1016\/j.xcrm.2023.101228","volume":"4","author":"M Liang","year":"2023","unstructured":"Liang, M. et al. Replenishing decoy extracellular vesicles inhibits phenotype remodeling of tissue-resident cells in inflammation-driven arthritis. Cell Rep. Med. 4, 101228 (2023).","journal-title":"Cell Rep. Med."},{"key":"70451_CR64","doi-asserted-by":"publisher","first-page":"120539","DOI":"10.1016\/j.biomaterials.2020.120539","volume":"269","author":"X Xu","year":"2021","unstructured":"Xu, X. et al. Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials 269, 120539 (2021).","journal-title":"Biomaterials"},{"key":"70451_CR65","doi-asserted-by":"publisher","first-page":"134371","DOI":"10.1016\/j.jhazmat.2024.134371","volume":"471","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Long-term 4-nonylphenol exposure drives cervical cell malignancy through MAPK-mediated ferroptosis inhibition. J. Hazard. Mater. 471, 134371 (2024).","journal-title":"J. Hazard. Mater."},{"key":"70451_CR66","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).","journal-title":"Nucleic Acids Res."},{"key":"70451_CR67","doi-asserted-by":"publisher","first-page":"583842","DOI":"10.3389\/fmed.2021.583842","volume":"8","author":"MI Mitrani","year":"2021","unstructured":"Mitrani, M. I. et al. Case Report: administration of amniotic fluid-derived nanoparticles in three severely Ill COVID-19 patients. Front. Med. 8, 583842 (2021).","journal-title":"Front. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70451-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:04:18Z","timestamp":1776902658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70451-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70451"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70451-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research has been filed for a patent under application number CN116769718A with W.Y. and H.Z. named as inventors. J.X. and H.Z. co-founded EVLiXiR Biotech Inc., where H.Z. serves as CEO and J.X. as chief scientist. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3726"}}